1 recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Recruiting 1 |
Follow TLX101-Tx: new trials by email Literature Review of TLX101-Tx trials Research Report on TLX101-Tx
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma TLX-101-Tx + Lomustine, TLX101-Tx - Neoplastic Disease, Glioblastoma | Phase 3 | Recruiting | Telix Pharmaceuticals (Innovations) Pty Limited | 50 | 2025-11-02 | 2026-08-11 |
Brain Neoplasms (1) · Central Nervous System Neoplasms (1) · Glioblastoma (1) · Neoplasm Recurrence, Local (1) · Neoplasms (1)
Telix Pharmaceuticals (Innovations) Pty Limited (1)
Australia (1) · Austria (1) · Belgium (1) · Netherlands (1)
2025 (1)